Bayer Aktiengesellschaft (WSE:BAY)
114.80
-3.70 (-3.12%)
Nov 20, 2025, 6:54 PM CET
Bayer Aktiengesellschaft Market Cap
Bayer Aktiengesellschaft has a market cap or net worth of 115 billion as of November 21, 2025. Its market cap has increased by 9.98% in one year.
Market Cap
115.00B
Enterprise Value
253.00B
Revenue
195.71B
Ranking
n/a
PE Ratio
n/a
Stock Price
114.80
Market Cap Chart
Since January 1, 1992, Bayer Aktiengesellschaft's market cap has increased from 13.77B to 115.00B, an increase of 735.11%. That is a compound annual growth rate of 6.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 115.00B | 41.84% |
| Dec 30, 2024 | 81.08B | -43.53% |
| Dec 29, 2023 | 143.58B | -35.37% |
| Dec 30, 2022 | 222.16B | 4.87% |
| Dec 30, 2021 | 211.85B | -2.25% |
| Dec 30, 2020 | 216.73B | -28.82% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.94B |
| NEUCA | 3.62B |
| Synektik Spólka Akcyjna | 2.22B |
| Voxel | 1.51B |
| Celon Pharma | 1.08B |
| Selvita | 805.81M |
| Centrum Medyczne ENEL-MED | 523.19M |
| Bioceltix | 447.63M |